Aggressive antiplatelet therapy reduces the risk of coronary stent thrombosis associated with the GPIIb/IIIa PLA2 polymorphism

被引：0
|
作者：
Walter, DH [1 ]
Elsner, M [1 ]
Goette, S [1 ]
Auch-Schwelk, W [1 ]
机构：
[1] Univ Frankfurt, D-6000 Frankfurt, Germany
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3744
引用
收藏
页码：709 / 710
页数：2
相关论文
共 40 条
  • [21] Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery
    Motovska, Zuzana
    DRUGS, 2011, 71 (14) : 1797 - 1806
  • [22] Management of Antiplatelet Therapy in Patients at Risk for Coronary Stent Thrombosis Undergoing Non-Cardiac Surgery
    Zuzana Motovska
    Drugs, 2011, 71 : 1797 - 1806
  • [23] PIA polymorphism of the platelet glycoprotein IIIa is associated with higher risk for restenosis after coronary stent placement
    Kastrati, A
    Seyfarth, M
    Koch, W
    Elezi, S
    Kettling, C
    Mehilli, J
    Schomig, K
    von Beckerath, N
    Seidl, H
    Schomig, A
    Herzzentrum, D
    CIRCULATION, 1998, 98 (17) : 434 - 434
  • [24] Optimalized individual antiplatelet therapy in high risk cardiovascular patients with coronary stent thrombosis and clopidogrel resistance
    Zsamboki, E. Toth
    Beres, B. J.
    Vargova, K.
    Bencze, J.
    Kerecsen, G.
    Csoti, E.
    Preda, I.
    Kiss, R. G.
    EUROPEAN HEART JOURNAL, 2006, 27 : 752 - 752
  • [25] ANTIPLATELET MONOCLONAL F(AB')2 ANTIBODY DIRECTED AGAINST THE PLATELET GPIIB-IIIA RECEPTOR COMPLEX PREVENTS CORONARY-ARTERY THROMBOSIS IN THE CANINE HEART
    MICKELSON, JK
    SIMPSON, PJ
    LUCCHESI, BR
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (04) : 393 - 405
  • [26] PlA1/A2 polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia
    Cenarro, A
    Casao, E
    Civeira, F
    Jensen, HK
    Faergeman, O
    Pocoví, M
    ATHEROSCLEROSIS, 1999, 143 (01) : 99 - 104
  • [27] Intraoperative Thrombosis of Right Coronary Artery Drug-Eluting Stent After 2 Years of Dual Antiplatelet Therapy
    Murray, Aaron T.
    Sederberg, James H., II
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 15 (1-2) : 40 - 43
  • [28] PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events
    Boroujeni, Hamid Rouhi
    Pourgheysari, Batoul
    Hasheminia, Ali
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [29] Human platelet antigen polymorphism HPA-1b (PLA2) as inherited risk factor for myocardial infarction in coronary artery disease
    Zotz, RB
    Winkelmann, BR
    Nauck, M
    Giers, G
    MaruhnDebowski, B
    Marz, W
    Scharf, RE
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1042 - P1042
  • [30] Prior Clopidogrel Therapy in Patients Presenting with Acute Coronary Syndromes (ACS) is Associated with Increase Risk of Stent Thrombosis
    Asher, Elad
    Biton, Yitsik
    Fink, Noam
    Herscovici, Romana
    Koifman, Edward
    Maor, Elad
    Sabbag, Avraham
    Fefer, Paul
    Beigel, Roy
    Matezky, Shlomi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B141 - B141
1234